Home > Insider Trading > Filing (0001209191-15-085630)

Filing Details

Accession Number:: 0001209191-15-085630
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-16 18:32:18
Reporting Period:: 2015-12-14

Filing Date:: 2015-12-16
Accepted Time:: 2015-12-16 18:32:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1493566	Otonomy Inc.	OTIC	Pharmaceutical Preparations (2834)	262590070

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1394692	Ii Michael Robert Savel	C/O Otonomy, Inc. 6275 Nancy Ridge Drive, Suite 100 San Diego CA 92121	Chief Technical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-12-14	3,412	$6.33	4,668	No	4	M	Direct
Common Stock	Acquisiton	2015-12-14	1,588	$1.76	6,256	No	4	M	Direct
Common Stock	Disposition	2015-12-14	2,322	$25.14	3,934	No	4	S	Direct
Common Stock	Disposition	2015-12-14	1,289	$26.15	2,645	No	4	S	Direct
Common Stock	Disposition	2015-12-14	1,289	$27.26	1,356	No	4	S	Direct
Common Stock	Disposition	2015-12-14	100	$27.70	1,256	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-12-14	3,412	$0.00	3,412	$6.33
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-12-14	1,588	$0.00	1,588	$1.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,994	2015-04-23	2024-06-03	No	4	M	Direct
79,047	2015-01-06	2024-01-31	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares purchased ranging from $24.63 to $25.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $25.64 to $26.62 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $26.66 to $27.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The sale price reported in Column 4 of Table I represents the weighted average sale price of the shares sold ranging from $27.70 to $27.73 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Of the total grant of 54,607 shares, one-fourth of the shares subject to the option vested on April 23, 2015 and one forty-eighth of the shares vest monthly thereafter.
Of the total grant of 92,434 shares, one-fourth of the shares subject to the option vested on January 6, 2015 and one forty-eighth of the shares vest monthly thereafter.